Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024.

Transl Breast Cancer Res · 2024 · PMC11341997 · PMID 39184927

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In the TORCHLIGHT study ( 42 ), toripalimab in combination with chemotherapy significantly improved PFS in PD-L1-positive (CPS ≥1) populations, with a clear trend towards OS benefit regardless of PD-L1 expression.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.